Přejít k hlavnímu obsahu

Přihlášení pro studenty

Přihlášení pro zaměstnance

Publikace detail

Low plasma levels of beta-carotene in obese men with advanced coronary artery disease
Autoři: Mužáková Vladimíra | Skalický Jiří | Kanďár Roman | Meloun Milan | Vojtíšek Petr | Roušar Tomáš | Kovařík Jakub
Rok: 2008
Druh publikace: článek ve sborníku
Název zdroje: Free Radical Research
Název nakladatele: Informa Healthcare UK
Místo vydání: London
Strana od-do: S110
Tituly:
Jazyk Název Abstrakt Klíčová slova
cze Nízké hladiny beta-karotenu u obézních osob s ischemickou chorobou srdeční Nízké hladiny beta-karotenu u obézních osob s ischemickou chorobou srdeční beta-karoten; ischemická choroba srdeční; oxidační stres
eng Low plasma levels of beta-carotene in obese men with advanced coronary artery disease Coronary heart disease (CHD) is the leading cause of morbidity and mortality in developed countries with west-east stratification. Differences in classical risk factors do not account for the variability in the incidence found in different populations. Considerable evidence indicates that oxidants are involved in the development and clinical expression of CHD and that antioxidants may contribute to disease resistance. An important lipid-soluble antioxidant dietary component is a-tocopherol, major chain-breaking antioxidant in body tissues, and b-carotene. Significant regional differences in plasma levels of these compounds were found. The aim of this study has been to determine plasma concentrations of b-carotene and a-tocopherol, the level of systemic inflammation and oxidative stress in patients with advanced coronary artery disease. Oxidative stress parameters were determined in group of patients with advanced coronary artery disease (at least 50% stenosis of the left main coronary artery or 70% stenosis of the epicardial coronary artery according to coronarographic examination; S, n=91) and control group of examined patients with normal coronary arteries (normal coronarographic status; C, n=49). Plasma levels of b-carotene, a-tocopherol and malondialdehyde were determined by HPLC, free radical concentration by direct method based on chlorophyllin acceptance of electrons. Plasma levels of high sensitive C-reactive protein, Interleukine-6 (IL-6), glucose, total cholesterol, triglycerides, HDL-ch, LDL-ch and fibrinogen were followed by standard procedures. In patients with coronary stenosis (S) lower levels of b-carotene (BC) and a-tocopherol (AT) coincided with higher level of inflammation and in lesser extent of free radicals (FR). BC: S: 0.10  0.11 mol/l vs C: 0.14  0.08 mol/l (p0.05); AT: S: 22.59  7.16 mol/l vs C: 23.75  5.95 (p>0.05); IL-6: S: 5.75  3.55 ng/l vs C: 3.92  2.76 Beta-carotene; coronary artery disease; oxidative stress